About: EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia. It operates in two segments, Meluka (Branded Wellness Consumer Products) and Nextract (Pharmaceutical Products and Intellectual Property). Its lead product is the Dyspro, a formulation developed to address dysmenorrhoea and Endometriosis Pain; and Libbo, an oral dissolving film for erectile dysfunction. The company also develops Apixaban to treat anticoagulation. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
Sector: Consumer Defensive
Industry: Packaged Foods
Latest price: A$0.01 (-7.14%)
EVE ASX EVE Health Group Limited
EVE Health Group Limited share price
Atividade de preço de EVE
Último preço
$ 0,010
Variação (24h)
-0,00 AUD (7,14%)
Volume
19.02K
Volume (média 4 sem.)
-
Abertura
$ 0,01
Variação do dia
$ 0,01 - $ 0,01
Fechamento anterior
$ 0,01
Último negócio
30 Oct, 2:38 am GMT+0
Atrasado
30 Oct, 2:38 am GMT+0
EVE price performance
Atrasado
30 Oct, 2:38 am GMT+0
quote.marketSignals